What is the short-term trade idea for AFMD stock?

Short-term traders can watch for a bounce above **$0.22** on volume above **15,650,229.00** shares, use a stop under **$0.16**, and keep position size small due to high volatility.

How does Affimed’s financial health affect AFMD stock?

Affimed shows cash per share **$4.88** and a current ratio **3.25**, giving liquidity, but EPS **-5.09** and negative margins increase execution and development risk for AFMD stock.

What catalysts could move AFMD stock higher?

Clinical readouts for AFM13 or AFM24, new collaborations, or better-than-expected cash flow updates could trigger a rally in AFMD stock, especially with elevated volume.

How reliable is the Meyka AI forecast for AFMD stock?

Meyka AI's forecasts are model-based. The 12-month **$0.60** projection is a statistical output, not a guarantee. Use it with fundamental review and risk controls for AFMD stock.

US Stocks

AFMD Affimed N.V. NASDAQ $0.18 pre-market 26 Jan 2026: oversold bounce insight

ByDanny Kontos January 26, 2026January 26, 2026

AFMD stock trades at $0.18 in the pre-market on NASDAQ in the United States on 26 Jan 2026, showing heavy volume of 22,062,730.00 shares and a yawning gap to its 200-day average of $1.76. This price puts Affimed N.V. (AFMD) deep in oversold territory after a steep multi-quarter decline from a year high of $8.95. Early momentum today suggests a possible short-term bounce trade, but investors should weigh volatile volume and weak earnings metrics before positioning.